SPAC Sponsor and Executives Disclose 21% Foundational Stake Post-IPO
summarizeSummary
IRHO SPAC SPONSOR LLC and its managing members, including the CEO and CFO, have disclosed a 21% beneficial ownership stake in Iron Horse Acquisition II Corp. following the company's IPO.
check_boxKey Events
-
Significant Ownership Stake
IRHO SPAC SPONSOR LLC, along with its managing members Jose Bengochea (CEO and Chairman) and William Caragol (CFO and Director), collectively beneficially own 6,120,000 ordinary shares, representing 21% of the company's outstanding shares.
-
Foundational Share Acquisition
The stake includes 5,750,000 founder shares acquired for a nominal price of $32,000 in September 2025, and 370,000 ordinary shares underlying private placement units purchased at $10.00 per unit simultaneously with the IPO closing on December 18, 2025.
-
Lock-Up Agreements in Place
The reporting persons are subject to lock-up agreements, restricting the transfer of founder shares for 180 days post-business combination (with certain performance-based early release conditions) and private placement units for 30 days post-business combination, demonstrating a long-term commitment.
auto_awesomeAnalysis
This Schedule 13D filing formally discloses the significant beneficial ownership of IRHO SPAC SPONSOR LLC and its managing members, Jose Bengochea (CEO and Chairman) and William Caragol (CFO and Director), following the company's initial public offering. Their combined 21% stake, valued at over $61 million, represents a substantial controlling interest in the SPAC. The disclosure of founder shares acquired at a nominal price and private placement units purchased at the IPO price, coupled with lock-up agreements, signals a strong alignment of interests between the sponsor, key executives, and future shareholders, which is a critical aspect for a SPAC's long-term strategy and eventual business combination.
At the time of this filing, IRHOU was trading at $9.97 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $235M. The 52-week trading range was $9.94 to $10.02. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.